Straumann Holding (SAUHY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Shares of Straumann (SIX:STMN) surged on Wednesday after it reported its second-quarter results, posting a solid performance that exceeded expectations in several key areas. Straumann surged 14.8% to CHF 127.10 at 5:01 am (0901 GMT). The company's sales for the quarter reached CHF 1,273 million, aligning closely with the consensus estimate of CHF 1,300 million.
(Reuters) -Dental implant maker Straumann announced the sale of its DrSmile aligner business and raised its full-year outlook to reflect that on Wednesday, after its half-year operating profit beat expectations. Straumann said it had signed an agreement to sell DrSmile to Barcelona-based clear aligner provider Impress Group. In April, it had said DrSmile was facing headwinds in the direct-to-consumer segment.